An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Title | PMID | PMCID | Public Release Type | Publication Year | DOI | Study Acronym | Study Network | Request ID(s) | Public Release Origin |
|---|---|---|---|---|---|---|---|---|---|
| Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. | 15239078 | Journal | 2004 | 10.1002/hep.20293 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. | 20305573 | PMC3618971 | Journal | 2010 | 10.231/JIM.0b013e3181db8764 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. | 16317692 | Journal | 2005 | 10.1002/hep.20948 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group. | 10545534 | Journal | 1999 | 10.1002/lt.500050607 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Acute liver failure due to amoxicillin and amoxicillin/clavulanate. | 16187174 | Journal | 2005 | 10.1007/s10620-005-2938-5 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Acute liver failure: Summary of a workshop. | 18318440 | PMC3381946 | Journal | 2008 | 10.1002/hep.22177 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Alpha-fetoprotein and prognosis in acute liver failure. | 17133565 | Journal | 2006 | 10.1002/lt.20886 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Angiogenin May be an Ealy Biomarker for Regeneration in Drug-Induced Liver Failure | Conference Presentation | 2021 | AALF | Acute Liver Failure Study Group (ALFSG) | 22995, 23360 | Secondary Research | |||
| Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. | 17657817 | PMC3731127 | Journal | 2007 | 10.1002/hep.21828 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Autoimmune acute liver failure: proposed clinical and histological criteria. | 21274872 | PMC3080034 | Journal | 2011 | 10.1002/hep.24080 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America. | 36825579 | PMC10192052 | Journal | 2023 | 10.1097/LVT.0000000000000105 | AALF | Acute Liver Failure Study Group (ALFSG) | 23360, 23358, 23359, 23373, 23456, 23499, 23498, 23523, 23550, 23779, 23818, 23880, 23969 | Secondary Research |
| Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. | 16964546 | Journal | 2006 | 10.1007/s10620-005-9061-5 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. | 24104197 | PMC3876784 | Journal | 2014 | 10.1124/dmd.113.053546 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. | 25203057 | PMC4329085 | Journal | 2015 | 10.1111/liv.12682 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. | 15720535 | Journal | 2005 | 10.1111/j.1365-2893.2005.00581.x | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Cytokine and autoantibody patterns in acute liver failure. | 20039781 | PMC4937798 | Journal | 2010 | 10.3109/15476910903501748 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. | 18825709 | PMC3618973 | Journal | 2008 | 10.1002/lt.21567 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. | 23775837 | PMC4940023 | Journal | 2014 | 10.1002/hep.26564 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Development of an accurate index for predicting outcomes of patients with acute liver failure. | 22885329 | PMC3480539 | Journal | 2012 | 10.1053/j.gastro.2012.07.113 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. | 20949552 | PMC3992250 | Journal | 2010 | 10.1002/hep.23937 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. | 23782487 | PMC4994536 | Journal | 2013 | 10.1111/liv.12214 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. | 24674942 | PMC4205208 | Journal | 2014 | 10.1016/j.cgh.2014.03.011 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? | 17538968 | Journal | 2007 | 10.1002/hep.21640 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. | 24464209 | PMC4250929 | Journal | 2014 | 10.1007/s10620-014-3029-2 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Etiology and outcome for 295 patients with acute liver failure in the United States. | 9873089 | Journal | 1999 | 10.1002/lt.500050102 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| False positive acetaminophen concentrations in patients with liver injury. | 18279672 | PMC3618976 | Journal | 2008 | 10.1016/j.cca.2008.01.018 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. | 17133489 | PMC3505613 | Journal | 2006 | 10.1002/hep.21439 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Gc-globulin and prognosis in acute liver failure. | 16184570 | Journal | 2005 | 10.1002/lt.20437 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome | 34562318 | Journal | 2021 | 10.1002/hep.32174 | AALF | Acute Liver Failure Study Group (ALFSG) | 23062 | Secondary Research | |
| Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. | 25239633 | PMC4250849 | Journal | 2014 | 10.1093/toxsci/kfu195 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Hepatitis B infection in patients with acute liver failure in the United States. | 11283862 | Journal | 2001 | 10.1053/jhep.2001.23065 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. | 23325162 | PMC3663882 | Journal | 2013 | 10.1007/s10620-012-2512-x | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Infection and the progression of hepatic encephalopathy in acute liver failure. | 12949721 | Journal | 2003 | 10.1016/s0016-5085(03)01051-5 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Influence of high body mass index on outcome in acute liver failure. | 16996806 | Journal | 2006 | 10.1016/j.cgh.2006.07.014 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. | 17901832 | Journal | 2007 | 10.1097/01.CCM.0000287592.94554.5F | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. | 19524577 | PMC3189485 | Journal | 2009 | 10.1053/j.gastro.2009.06.006 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. | 22213561 | PMC3378702 | Journal | 2012 | 10.1002/hep.25551 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. | 14624381 | Journal | 2003 | 10.1086/379216 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. | 20538000 | PMC3249217 | Journal | 2010 | 10.1053/j.gastro.2010.06.007 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Malignant infiltration of the liver presenting as acute liver failure. | 25277846 | PMC4379128 | Journal | 2015 | 10.1016/j.cgh.2014.09.040 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. | 16530510 | Journal | 2006 | 10.1053/j.gastro.2006.01.033 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. | 24895202 | PMC4930851 | Journal | 2014 | 10.1002/jmv.23987 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. | 21703173 | PMC4944117 | Journal | 2012 | 10.1016/j.jhep.2011.04.020 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Outcome of acute liver failure in the elderly. | 19877205 | PMC3123453 | Journal | 2009 | 10.1002/lt.21865 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. | 24351370 | PMC4563984 | Journal | 2014 | 10.1097/CCM.0000000000000144 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Pathogenesis of liver injury in acute liver failure. | 22796239 | PMC3641754 | Journal | 2012 | 10.1053/j.gastro.2012.07.011 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. | 19439490 | PMC2712440 | Journal | 2009 | 10.1124/dmd.108.026195 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Predictive value of actin-free Gc-globulin in acute liver failure. | 17763387 | Journal | 2007 | 10.1002/lt.21236 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | ||
| Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. | 23780824 | PMC3775983 | Journal | 2013 | 10.1002/lt.23688 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study | |
| Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States. | 19501192 | PMC3642774 | Journal | 2009 | 10.1016/j.cgh.2009.05.029 | AALF | Acute Liver Failure Study Group (ALFSG) | Contributing Study |